Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Basel Medical Group Ltd (BMGL:NASDAQ), powered by AI.
Basel Medical Group Ltd is currently trading at $0.59. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Basel Medical Group Ltd on Alpha Lenz.
View Basel Medical Group Ltd's valuation metrics on Alpha Lenz.
“Basel Medical Group Ltd's ROE is -194.6%. Explore profitability and growth together.”
Ask for details →Basel Medical Group Ltd is a healthcare services provider headquartered in Singapore, operating primarily through its specialized medical clinics. The company focuses on general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, offering procedures such as knee and hip replacements, spine surgery, minimally invasive techniques, and comprehensive consultations and diagnostics. Basel Medical Group has established itself within Singapore's healthcare sector and recently expanded its presence through the acquisition of Bethesda Medical Pte. Ltd., a move that broadened its service portfolio to include diagnostic imaging, outpatient care, occupational health, women's health, mental health, and seafarer health services. This integration aims to streamline referrals and enhance patient outcomes throughout the region. Founded in 2001 and incorporated as a public entity in 2023, Basel Medical Group plays an important role in meeting the growing healthcare needs of Southeast Asia by combining specialized care with broader outpatient and preventive services, positioning itself as a dynamic participant in the regional medical landscape.
“Basel Medical Group Ltd's ROE is -194.6%. Explore profitability and growth together.”
Ask for details →